elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Antibody-drug conjugate
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Application
keyword
Antibody-drug conjugate
RIS
0.001
(Research Intensity Score)
Papers
168
Top papers
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
2023 · 492 citations
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
2025 · 236 citations
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
2026 · 113 citations
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
2023 · 251 citations
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
2025 · 98 citations
Newest papers
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
2026 · 113 citations
Tumor Targeting with Peptide-Drug Conjugates: Showcasing Key Progress and Hurdles
2026 · 15 citations
Mocertatug rezetecan (GSK5733584), a B7-H4-targeted antibody-drug conjugate (ADC), in platinum-resistant ovarian cancer (PROC) and endometrial cancer (EC): First results from the global BEHOLD-1 study
2026 · 6 citations
A randomized phase II trial of mirvetuximab soravtansine in folate receptor alpha (FRα)–high recurrent ovarian cancer eligible for platinum-based chemotherapy (MIROVA/AGO-OVAR 2.34).
2026 · 4 citations
Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science
2026 · 3 citations
A sample from the 100 top papers behind Antibody-drug conjugate.
Create a free account to browse them all →
Antibody-drug conjugate's history
Research intensity over time
Explore Antibody-drug conjugate's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Antibody-drug conjugate's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link